Portal Hypertension and Varices: What Every Liver Patient Should Know

If you have cirrhosis or advanced liver disease, one of the most serious complications you need to understand is portal hypertension — and the dangerous enlarged blood vessels called varices that it can cause. Variceal bleeding is a medical emergency that claims lives, yet with proper screening, medication, and monitoring, it is largely preventable.

This guide explains what portal hypertension is, how it develops, why it causes varices, how varices are detected and treated, the warning signs you must never ignore, and how keeping track of your liver health helps your medical team protect you from this life-threatening complication.

⚡ Know Your Risk Level

Your FibroScan results can help determine whether you have clinically significant portal hypertension. Use our free FibroScan Interpreter to understand your liver stiffness score, or check your disease severity with the MELD Score Calculator.

What Is Portal Hypertension?

Portal hypertension is abnormally high blood pressure in the portal vein system — the network of blood vessels that carries blood from your intestines, stomach, spleen, and pancreas to your liver for processing. In a healthy liver, blood flows through the liver easily. But when the liver is damaged by cirrhosis, scar tissue blocks and compresses the small blood vessels inside the liver, creating resistance to blood flow. This resistance causes the pressure in the portal vein to rise.

Portal hypertension is measured by the hepatic venous pressure gradient (HVPG) — the difference in pressure between the portal vein and the hepatic veins. A normal HVPG is 1–5 mmHg. When it rises above 10 mmHg, it becomes what doctors call clinically significant portal hypertension (CSPH) — the threshold at which serious complications can begin to develop.

Why Portal Hypertension Matters

Portal hypertension is the root cause of nearly all major complications of cirrhosis. It is the driving force behind ascites (fluid buildup in the abdomen), esophageal and gastric varices (the focus of this article), splenomegaly (enlarged spleen leading to low platelet counts), hepatic encephalopathy (toxin buildup affecting brain function), and hepatorenal syndrome (kidney failure secondary to liver disease).

The transition from compensated to decompensated cirrhosis is largely driven by worsening portal hypertension. This is why the 2024 AASLD Practice Guidance now recommends that every patient with compensated cirrhosis should be assessed for CSPH as a routine part of their care.

How Portal Hypertension Causes Varices

When blood can't flow normally through the scarred liver, it's forced to find alternate routes — detour pathways called portosystemic collaterals. The blood reroutes through smaller, thinner-walled blood vessels that were never designed to handle this much pressure and volume. These vessels become swollen, stretched, and fragile — creating varices.

The most dangerous varices form in two locations:

• Esophageal varices: Enlarged veins in the lower esophagus (the tube connecting your throat to your stomach). These are the most common and most clinically significant type.

• Gastric varices: Enlarged veins in the upper part of the stomach, particularly around the gastric fundus. Less common but can bleed more severely when they rupture.

In patients with compensated cirrhosis, the prevalence of any varices is approximately 30–40%. Only a minority (10–20%) of those have high-risk varices that require treatment. However, once present, varices can enlarge over time, especially if the underlying liver disease progresses and portal pressure continues to rise.

Who Is at Risk for Varices?

Not every cirrhosis patient develops varices. Your risk depends on several factors:

• Severity of cirrhosis: More advanced cirrhosis (higher Child-Pugh class) = higher risk of varices

• Liver stiffness on FibroScan: Liver stiffness above 20–25 kPa is strongly associated with CSPH. Above 25 kPa, CSPH can be "ruled in" noninvasively

• Platelet count: Low platelets (below 150,000/µL) suggest portal hypertension and splenic sequestration. The combination of liver stiffness ≥20 kPa and platelets <150,000 is used by the Baveno VII guidelines to identify patients needing endoscopic screening

• MELD score: Higher MELD scores correlate with more severe portal hypertension

• Cause of liver disease: Alcohol-related cirrhosis and hepatitis C cirrhosis have particularly high rates of varices

• Ongoing liver injury: Continued alcohol use, untreated hepatitis, or uncontrolled NAFLD/NASH accelerates portal hypertension progression

📊 Check Your Risk Noninvasively

If your liver stiffness is below 20 kPa AND your platelet count is above 150,000, you have less than a 5% chance of having high-risk varices — and may be able to avoid screening endoscopy. Use the FibroScan Interpreter and upload your labs to the report tracker to monitor these values.

How Are Varices Detected? Screening and Surveillance

Upper Endoscopy (EGD)

The traditional gold standard for detecting varices is an upper endoscopy (esophagogastroduodenoscopy or EGD). A thin, flexible tube with a camera is passed through your mouth into your esophagus and stomach. The doctor can directly see whether varices are present and classify them by size (small, medium, or large) and appearance (red wale marks, which indicate higher rupture risk).

The Role of Non-Invasive Testing (Avoiding Unnecessary Endoscopies)

A major advancement in recent years — endorsed by both the 2024 AASLD Practice Guidance and the Baveno VII consensus — is using non-invasive tests to identify patients who DON'T need endoscopy. This spares many patients from an invasive procedure they don't need.

The key rule: if your FibroScan liver stiffness is below 20 kPa and your platelet count is above 150,000/µL, you can safely skip screening endoscopy — the risk of having high-risk varices is less than 5%. This applies to roughly 30% of patients with advanced chronic liver disease.

If your liver stiffness is above 20–25 kPa or your platelets are below 150,000, endoscopic screening is recommended.

How Often Should You Be Screened?

Track your FibroScan results with the FibroScan Tracker and your platelet counts (from lab reports) via the report tracker — the trend tracking feature shows whether these values are worsening over time, which may signal the need for endoscopy.

Warning Signs of Variceal Bleeding: When to Call 911

Variceal bleeding is a medical emergency. The 6-week mortality rate for acute variceal hemorrhage ranges from 10–15% even with modern treatment. Recognizing the warning signs can save your life.

Call 911 or go to the emergency room IMMEDIATELY if you experience:

• Vomiting blood (hematemesis): Blood may be bright red or look like dark "coffee grounds"

• Black, tarry stools (melena): Indicates blood that has been digested as it passed through your GI tract

• Bloody or maroon-colored stools (hematochezia): Indicates rapid, significant GI bleeding

• Lightheadedness, dizziness, or fainting: Signs of blood loss and dropping blood pressure

• Rapid heart rate (tachycardia): Your heart compensating for blood volume loss

• Pale, clammy skin and cold sweats: Signs of shock from blood loss

• Sudden confusion or loss of consciousness: May indicate severe blood loss or hepatic encephalopathy triggered by the bleed

Do NOT wait to "see if it gets better." Variceal bleeding can be massive and fatal within hours. Even a single episode of vomiting blood or passing black stools in a patient with known cirrhosis should trigger an emergency room visit.

How Are Varices Treated?

Treatment for varices depends on whether you're preventing a first bleed (primary prophylaxis), treating an active bleed (acute management), or preventing rebleeding (secondary prophylaxis).

1. Primary Prophylaxis (Preventing the First Bleed)

The goal is to reduce portal pressure and prevent varices from ever rupturing.

Non-Selective Beta-Blockers (NSBBs) — the first-line treatment:

• Carvedilol is now the preferred NSBB according to the latest AASLD guidance. It reduces portal pressure more effectively than older beta-blockers and may also prevent decompensation in patients with CSPH. Starting dose is typically 6.25 mg/day, titrated up to 12.5 mg/day.

• Propranolol and nadolol are alternatives if carvedilol isn't tolerated.

• NSBBs work by reducing heart rate and cardiac output (lowering blood flow into the portal system) and by constricting splanchnic blood vessels.

A major paradigm shift in the latest guidelines: the 2024 AASLD guidance now recommends starting carvedilol in patients with CSPH even before varices develop, to prevent both variceal formation and decompensation. This was driven by the landmark PREDESCI trial, which showed that early beta-blocker therapy reduces the risk of hepatic decompensation.

Endoscopic Variceal Ligation (EVL / Banding): For patients who cannot tolerate beta-blockers, EVL is an alternative. Small rubber bands are placed around the varices during endoscopy, causing them to shrink and eventually fall off. EVL is typically repeated every 2–6 weeks until varices are eradicated.

2. Acute Variceal Hemorrhage (Active Bleeding)

Active variceal bleeding requires immediate hospital treatment:

• Hemodynamic stabilization: IV fluids and blood transfusions (targeting hemoglobin of 7–8 g/dL — over-transfusion can worsen portal pressure)

• Vasoactive drugs: Octreotide or terlipressin — started immediately to reduce portal blood flow and pressure

• Antibiotics: Given prophylactically to prevent infection (typically ceftriaxone), which is a major cause of death in variceal bleeding

• Emergency endoscopy: Performed within 12 hours to identify the bleeding source and apply EVL (banding)

• Preemptive TIPS: The latest AASLD guidance endorses early TIPS (transjugular intrahepatic portosystemic shunt) placement within 72 hours for high-risk patients (Child-Pugh B with active bleeding or Child-Pugh C score 10–13) — this has been shown to significantly reduce rebleeding and mortality

3. Secondary Prophylaxis (Preventing Rebleeding)

After a first variceal bleed, the risk of rebleeding within one year can be as high as 60% without treatment. The standard approach is combination therapy: NSBBs (used indefinitely) plus EVL (repeated every 2–6 weeks until varices are eradicated, then surveillance endoscopy every 3–12 months). Patients who received a TIPS during the acute episode do not need NSBBs or EVL, as the shunt resolves portal hypertension.

TIPS: The Shunt Procedure Explained

TIPS (Transjugular Intrahepatic Portosystemic Shunt) is a procedure where an interventional radiologist creates a new channel within the liver that connects the portal vein directly to the hepatic vein, bypassing the scarred liver tissue. This dramatically reduces portal pressure and blood flow through the varices.

TIPS is used in several situations: as a preemptive measure during acute variceal hemorrhage (in high-risk patients), for refractory variceal bleeding (when medications and banding fail), for refractory ascites (fluid buildup unresponsive to diuretics), and as a bridge to liver transplant.

The major side effect of TIPS is hepatic encephalopathy — because the shunt diverts blood (and toxins) away from the liver, ammonia levels can rise, causing confusion and other neurological symptoms. This occurs in approximately 20–30% of patients after TIPS and is managed with lactulose and rifaximin.

Portal Hypertension, Varices, and Your Clinical Scores

Portal hypertension connects directly to the clinical scores your doctor uses to assess your disease:

• MELD score: While portal pressure isn't directly in the MELD formula, the kidney dysfunction and sodium imbalances caused by portal hypertension drive creatinine up and sodium down — both of which increase your MELD-Na score.

• Child-Pugh score: Ascites (driven by portal hypertension) is one of the five Child-Pugh components. Variceal bleeding moves you from compensated (Class A) to decompensated (Class B/C).

• FibroScan liver stiffness: Values above 20–25 kPa strongly predict CSPH. Tracking your FibroScan over time with the FibroScan Tracker shows whether your portal hypertension risk is increasing.

• Platelet count: Low platelets (visible in your blood tests) are a marker of portal hypertension and spleen enlargement. Track this through the report tracker.

Calculate your scores instantly with the MELD Score Calculator.

How to Protect Yourself: Practical Steps

If You Have Compensated Cirrhosis Without Known Varices

• Get your FibroScan and platelet count checked regularly — track results with LiverTracker's FibroScan Tracker

• If your liver stiffness rises above 20 kPa or platelets fall below 150,000 — discuss endoscopic screening with your hepatologist

• Treat the underlying cause of your liver disease aggressively (antiviral therapy, alcohol abstinence, weight loss for NAFLD)

• Ask your doctor about starting carvedilol if CSPH is suspected — early beta-blocker therapy can prevent decompensation

If You Have Known Varices

• Take your beta-blocker medication every single day — missing doses increases rupture risk

• Attend all scheduled endoscopy appointments

• Avoid NSAIDs (ibuprofen, aspirin, naproxen) — they increase bleeding risk

• Follow sodium restriction guidelines to help manage portal hypertension and ascites

• Avoid heavy lifting or straining — increased abdominal pressure can trigger variceal bleeding

• Limit alcohol completely — any amount worsens portal hypertension

• Upload every lab report to LiverTracker and use the trend tracking feature to spot worsening values early

Know Your Emergency Plan

Discuss with your transplant team or hepatologist what to do if you experience signs of bleeding. Know the nearest emergency room with a liver/GI specialist available 24/7. Carry a medical card or wear a medical bracelet identifying you as a cirrhosis patient with varices.

🚀 Track Your Portal Hypertension Risk

1. Use the FibroScan Interpreter to understand your liver stiffness and what it means for portal hypertension.

2. Create your free LiverTracker account to upload labs, track platelets and liver enzymes, log FibroScan and endoscopy results, and monitor your MELD and Child-Pugh scores.

3. Use the doctor sharing feature to share your complete data with your hepatologist before every visit.

Frequently Asked Questions

Can varices go away?

Varices can shrink or disappear if the underlying portal hypertension is reduced. This can happen after successful hepatitis C cure, sustained alcohol abstinence, or TIPS placement. Beta-blockers and EVL also reduce variceal size. However, varices typically don't resolve on their own — they require treatment of the underlying cause and/or direct therapy.

Do all cirrhosis patients get varices?

No. At the time of diagnosis, approximately 30–40% of compensated cirrhosis patients have varices. The risk increases as cirrhosis progresses. Patients without CSPH (liver stiffness <20 kPa, platelets >150K) have a very low risk of developing varices in the next several years.

Can I exercise if I have varices?

Moderate exercise (walking, light cycling) is generally safe and beneficial. However, avoid heavy lifting, straining, and any activity that significantly increases abdominal pressure (Valsalva maneuver). Always discuss exercise with your hepatologist, who can give guidance based on your specific situation.

What foods should I avoid with portal hypertension?

Focus on sodium restriction (less than 2,000 mg/day) to help manage fluid retention and portal hypertension. Avoid alcohol completely. Eat soft foods if your varices are large (to avoid mechanical irritation). Use the food scanner to check foods for liver safety and explore the recipe center for liver-friendly meals.

How does FibroScan relate to portal hypertension?

FibroScan measures liver stiffness, which correlates strongly with portal pressure. Liver stiffness above 20–25 kPa is used as a noninvasive marker for CSPH. This is why the Baveno VII guidelines and AASLD guidance use FibroScan results (combined with platelet count) to determine who needs endoscopic screening for varices. Track your results with the FibroScan Tracker.

What is the Baveno VII rule?

Baveno VII is an international consensus guideline that states: patients with compensated advanced chronic liver disease whose liver stiffness is below 20 kPa and platelet count is above 150,000/µL can safely avoid screening endoscopy because their risk of having high-risk varices is less than 5%. This rule spares many patients from unnecessary endoscopies and has been widely adopted.

Medical References & Sources

1. Kaplan DE, Bosch J, Ripoll C, et al. AASLD practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis. Hepatology. 2024. PubMed

2. Brown RS Jr, et al. Screening and management of portal hypertension and varices in cirrhosis: Expert perspectives. Hepatology Communications. 2025;9(4). PMC Full Text

3. Bruni A, et al. New practice guidelines on risk stratification and management of portal hypertension. Hepatobiliary Surg Nutr. 2025. PMC Full Text

4. Garcia-Tsao G. Screening and surveillance of varices in patients with cirrhosis. Hepatology. 2018. PMC Full Text

5. AASLD. Portal Hypertensive Bleeding in Cirrhosis. AASLD Guidelines Page

6. DDW News. New AASLD Guidance Suggests Major Changes for Portal Hypertension Management. January 2026. DDW News

Related Articles & Tools on LiverTracker

• What Is a FibroScan? How Non-Invasive Liver Testing Works

• Cirrhosis Stages Explained: From Compensated to Decompensated

• Living with Ascites: Causes, Symptoms, and How to Track Fluid Retention

• What Is MELD Score? A Patient-Friendly Guide

• Child-Pugh Score Explained

• Why Sodium Matters in Liver Disease

• Understanding the Liver Transplant Waiting List

• NAFLD vs NASH: What's the Difference?

• Complete Guide to Liver Function Tests

• FibroScan Interpreter Tool

• MELD Score Calculator

• Liver Enzyme Checker

• FibroScan Tracker Feature

• Imaging Tracker (Endoscopy, Ultrasound, CT, MRI)

• Browse All Articles

🎯 Take Control of Your Liver Health Today

LiverTracker is the only platform built specifically for liver disease patients. Upload lab reports, track FibroScan results, log endoscopy and imaging reports, monitor all your trends, scan foods, plan liver-friendly meals, get AI-powered health answers, and share reports with your doctor.

→ Try the Free FibroScan Interpreter

→ Create Your Free Account

→ Download the iOS App

Medical Disclaimer: This article is for informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your hepatologist, gastroenterologist, or transplant team for guidance specific to your condition. LiverTracker does not provide medical advice. For our complete disclaimer, visit livertracker.com/medical-disclaimer.